PROCEPT BioRobotics (PRCT) Share-based Compensation (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Share-based Compensation data on file, last reported at $13.1 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 29.32% year-over-year to $13.1 million in Q1 2026; TTM through Mar 2026 was $50.6 million, a 41.68% increase from a year earlier, with the FY2025 full-year figure at $47.6 million, up 49.51% from the prior year.
• Share-based Compensation for Q1 2026 stood at $13.1 million, up from $10.8 million in the prior quarter.
• Over the last five years, Share-based Compensation for PRCT reached as high as $18.4 million in Q3 2022 and fell as low as $186000.0 in Q4 2022.
• Historically, Share-based Compensation has averaged $7.9 million across 5 years, with a median of $8.0 million in 2024.
• On a YoY basis, Share-based Compensation climbed as much as 2577.96% in 2023 and fell as far as 71.12% in 2023.
• Year by year, Share-based Compensation stood at $186000.0 in 2022, then soared by 2577.96% to $5.0 million in 2023, then soared by 82.39% to $9.1 million in 2024, then advanced by 19.34% to $10.8 million in 2025, then increased by 20.57% to $13.1 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $13.1 million in Q1 2026, $10.8 million in Q4 2025, and $14.5 million in Q3 2025.